Navigation Links
GC-Rise Attracts Attention in Health Capital Market
Date:3/18/2013

BEIJING, March 18, 2013 /PRNewswire/ -- GC-Rise Pharmaceutical Co. Ltd, in which European healthcare venture capital firm INVENTAGES holds a majority stake, attracted the attention of investors at the annual China Healthcare Investment Conference in Shanghai.

Beijing-headquartered GC-Rise, which focuses on women's and children's health in China, took the opportunity to showcase its growth stories and seek tie-ups with partners from the most promising public and private Chinese healthcare companies.

The conference was held from March 12-14 in Shanghai. GC-Rise presented the company's growth roadmap and new initiatives for 2013 at the event last Thursday.

On top of the new moves, the pediatrics pharmaceutical market has been incorporated into GC-Rise's specialties, reshaping the company's five strategic focuses into anti-aging products, respiratory diseases in children, pregnancy & new born health, skin care products, and mental health & child development.

"The market size of GC-Rise's strategic focus in China's women's and children's health is expected to see compound annual growth rate of 28% over the period of 2010-2017 due to growing healthcare awareness," said Wren Zhang, the Strategic Director of GC-Rise.

Furthermore, GC-Rise will foray into point-of-care testing (POCT) in the OB-GYN & pediatrics market taking advantages of the company's broad commercial channels and close connections with physicians.

"Technical advancements have helped the POCT market grow at a double digit CAGR from 2009 to 2011, which is expected to reach US$25 billion worldwide by 2016, while China will be one of the fastest growth drivers," Wren said.

GC-Rise, founded in 2008, has seen rapid growth over five years of continuous expansion. The compa
'/>"/>

SOURCE GC-Rise Pharmaceutical Co., Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Womens Health Expert GC-Rise Holds Menopause Health Talk
2. Women Health Expert GC-Rise Launches Obstetrician-gynecologist Prize
3. Tucson Symposium attracts over 450 global scientists focused on personalized healthcare
4. Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
5. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
6. Polish Medicine Attracts Patients From Abroad - Not Only During EURO 2012
7. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
8. More than Morning Sickness: Kate Middletons Pregnancy Announcement Draws Attention to Rare Pregnancy Condition Known as Hyperemesis Gravidarum (HG)
9. Attention Veterans: New Medtech Job Training Program Accepting Applications through Friday, August 31
10. Texas Medicaid Managed-Care Problems Gaining National Attention
11. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Nevro Corp. (NYSE: NVRO ... innovative evidence-based solutions for the treatment of chronic pain, ... response to the Patent Trial and Appeals Board (PTAB) ... review (IPR), filed by a unit of Boston Scientific ... Patent No. 8,359,102 (the ,102 patent). The ,102 patent is ...
(Date:9/1/2015)... and BRUSSELS , ... ) and UCB (Euronext Brussels: UCB) today announced ... effect of RomosozUmab Compared with Teriparatide in postmenopaUsal ... pReviously treated with bisphosphonatE therapy). The study (NCT01796301) ... difference in favor of romosozumab in the percent ...
(Date:9/1/2015)... , Sept. 1, 2015 Konica Minolta Medical ... Radiography (CR) system, designed to deliver enterprise level imaging ... the same Control Station as the Konica Minolta AeroDR ... an upgrade path from CR to DR. The SIGMA ... help improve workflow with unparalleled reliability and high capacity ...
Breaking Medicine Technology:Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2
... March 21, 2008, HOUSTON, March 3 ... new policies, a national alliance of,scientists, public health ... on a series of proposals designed to eliminate,continued ... of the four year initiative, Eliminating Disparities in,Clinical ...
... Significant Pain Relief with the 2.5 ... and 5 mg Doses Compared to ... (Nasdaq: ALXA ) announced today positive top-line,results from its ... patients with migraine headache. Migraine is a debilitating,yet common neurological ...
Cached Medicine Technology:EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations 2Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 2Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 3Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 4Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 5Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 6Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 7Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 8
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 article ... surgeries conducted each year on teenagers, quoting a New York City-area plastic surgeon ... plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to patients and ...
(Date:9/1/2015)... ... 01, 2015 , ... The Capillus82™ has been cleared by ... in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA clearance substantiates the ... when used at home to combat hair loss. , “Following the success ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... therapy company, is pleased to announce their partnership with Apex Physical Therapy ... both groups to continue to provide kind, compassionate, and empathetic care to local ...
(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... From ... 86 children and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at ... staff included 65 adult counselors, some of whom work for Calvary, and two junior ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... cure and prevent different malignancies. Some options for cancer treatment are available ... to which distinctive approach is necessary for effective treatment. Several molecules have ...
Breaking Medicine News(10 mins):Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3
... live a happy married life beat stress better than those ... a best stress buster//. ,Popular perception is that single ... that being in a loving relationship makes it easier to ... online edition of Daily Mail. ,Psychologist Dr Roxane ...
... epidemic proportions, forcing changes in many aspects of that ... fleet of ambulances to cope with a sharp rise ... been introduced and new air ambulances will be remodeled ... equipped with heavy-duty stretchers, capable of carrying patients weighing ...
... are discovering that some foods and supplements do have an ... killer- the ‘big C’. At the 233rd national meeting of ... dozen research papers on this topic will be presented. ... show promise for preventing cancer of the esophagus, colon — ...
... to increase libido in women will hit the market soon. This ... by the European Medicines Agency. ,This patch could be ... the male hormone testosterone into the bloodstream. Intrinsa is intended for ... patch is similar to Viagra for men and is said to ...
... was conducted in all mental health units in England ... in mixed wards//. This is much against the government’s ... hospitals. ,The healthcare commission reports that 55% ... bathrooms with the opposite sex. This practice has resulted ...
... A combination of AZT, lamivudine, and nevirapine (AZT/3TC/NVP) taken ... month after delivery resulted in significantly reduced HIV levels ... found in the breast milk of women who were ... (Drug Resource Enhancement Against AIDS and Malnutrition) in Mozambique ...
Cached Medicine News:Health News:Emboldened Warriors-Cancer Fighting Foods 2Health News:Emboldened Warriors-Cancer Fighting Foods 3Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 2Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 3Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: